---  
layout: startup_page  
title: "Kenai Therapeutics"  
id: "kenaitx.com"  
permalink: "/kenaitherapeuticskenaitx.com02292024/"  
website: "https://www.kenaitx.com"  
funding_round: "Series A"  
funding_amount: "$82M"  
investors: "Alaska Permanent Fund Corporation, Cure Ventures, The Column Group, Euclidean Capital, Saisei Ventures"  
about: "Kenai Therapeutics is a biotechnology company developing allogeneic neuron replacement cell therapies for neurological disorders using induced pluripotent stem cell (iPSC) technology. Their lead candidate, RNDP-001, targets Parkinson's disease and has shown promising results in preclinical models. The company aims to provide curative treatments for patients with limited treatment options."  
markets: "Biotechnology, Cell Therapy, Neurology, Drug Discovery"  
hq: "San Diego, California, United States"  
founded_year: "2022"  
linkedin: "https://www.linkedin.com/company/kenaitx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: "https://pitchbook.com/profiles/company/495860-50"  

date_display: "29-Feb-2024"  
date: "2024-02-29"

# SEO Optimization  
meta_title: "Kenai Therapeutics - Series A Funding ($82M)"  
meta_description: "Kenai Therapeutics, Kenai Therapeutics is a biotechnology company developing allogeneic neuron replacement cell therapies for neurological disorders using induced pluripo..."  
meta_keywords: "Kenai Therapeutics, Biotechnology, Cell Therapy, Neurology, Drug Discovery, Series A funding"  
canonical_url: "https://startup.projectstartups.com/kenaitherapeuticskenaitx.com02292024/"  
---